<a href="https://laohu8.com/S/CABA">Cabaletta Bio</a> Inc. Announces Repricing of Stock Options to Retain and Motivate Employees
Cabaletta Bio Inc. has announced a repricing of stock options for current employees, directors, and key consultants, effective May 19, 2025. The repricing affects options granted under the company's 2018 and 2019 Stock Option Plans, specifically targeting those with exercise prices exceeding 1.5 times the company's common stock closing price on the Nasdaq Global Select Market as of the effective date. The new exercise price for eligible options is set at $1.92. To benefit from the reduced exercise price, participants must remain with the company through a defined retention period, which concludes either on May 19, 2026, upon a sale event, or due to the participant's death or disability. The board approved this measure after careful deliberation, aiming to address the fact that approximately 75% of stock options were previously "underwater."
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cabaletta Bio Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0000950170-25-074589), on May 19, 2025, and is solely responsible for the information contained therein.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。